Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19241-37-3

Post Buying Request

19241-37-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19241-37-3 Usage

Description

3-Chloro-4-methylphenyl isothiocyanate is an organic compound that serves as a versatile reagent in the synthesis of various chemical compounds. It is characterized by its ability to form 1,2,4-thiadiazole derivatives and thio analogues of urea herbicides, making it a valuable component in the development of neuroprotectors and agrochemicals.

Uses

Used in Pharmaceutical Industry:
3-Chloro-4-methylphenyl isothiocyanate is used as a reagent for the synthesis of 1,2,4-thiadiazole derivatives, such as 5-Amino-1,2,3-thiadiazole (A630295). These compounds have demonstrated neuroprotective properties, making them valuable in the development of treatments for neurological disorders.
Used in Agrochemical Industry:
3-Chloro-4-methylphenyl isothiocyanate is also used as a reagent to synthesize thio analogues of urea herbicides, such as Fenuron (F279490). These analogues exhibit potent fungicidal activity, making them useful in the development of effective and environmentally friendly pesticides for the control of various plant diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 19241-37-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,2,4 and 1 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19241-37:
(7*1)+(6*9)+(5*2)+(4*4)+(3*1)+(2*3)+(1*7)=103
103 % 10 = 3
So 19241-37-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H6ClNS/c1-6-2-3-7(10-5-11)4-8(6)9/h2-4H,1H3

19241-37-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A19092)  3-Chloro-4-methylphenyl isothiocyanate, 98%   

  • 19241-37-3

  • 5g

  • 545.0CNY

  • Detail
  • Alfa Aesar

  • (A19092)  3-Chloro-4-methylphenyl isothiocyanate, 98%   

  • 19241-37-3

  • 25g

  • 1422.0CNY

  • Detail

19241-37-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-chloro-4-isothiocyanato-1-methylbenzene

1.2 Other means of identification

Product number -
Other names 3-CHLORO-4-METHYLPHENYL ISOTHIOCYANATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19241-37-3 SDS

19241-37-3Relevant articles and documents

A catalyst-free method for the synthesis of 1,4,2-dithiazoles from isothiocyanates and hydroxylamine triflic acid salts

An, Zhenyu,Liu, Yafeng,Ren, Yi,Wang, Ting,Yan, Rulong

supporting information, p. 6206 - 6209 (2021/07/28)

A catalyst-free method for the preparation of 1,4,2-dithiazoles is developed by reactions of isothiocyanates with hydroxylamine triflic acid salts. This reaction achieves C-S, C-N, and S-N bond formation, and a range of products are obtained in moderate to good yields. The obvious feature is using shelf-stable hydroxylamine triflic acid salts as a N source to synthesize heterocycles under mild conditions.

Synthesis and biological evaluation of terminal functionalized thiourea-containing dipeptides as antitumor agents

Huang, Ri-Zhen,Zhang, Bin,Huang, Xiao-Chao,Liang, Gui-Bin,Qin, Jian-Mei,Pan, Ying-Ming,Liao, Zhi-Xin,Wang, Heng-Shan

, p. 8866 - 8878 (2017/02/10)

A series of antitumor agents based on terminal functionalized dipeptide derivatives containing the thiourea moiety were synthesized and evaluated for antiproliferative activity using a panel of cancer cell lines, and the effects and mechanism of apoptosis induction were determined. These compounds exhibited significant selectivity to different cancer cell lines with IC50 values at micromolar concentrations. In particular, compound I-11 appeared to be the most potent compound, with an IC50 = 4.85 ± 1.44 μM against the NCI-H460 cell line, at least partly, by the induction of apoptosis. Mechanistically, compound I-11 induced the activation of caspase-12 and CHOP, which triggered apoptotic signalling via the ROS-dependent endoplasmic reticulum pathway and arrested the cell cycle at the S phase. Thus, we concluded that dipeptide derivatives containing the thiourea moiety terminally functionalized by electron-withdrawing substituents may be potential antitumor agents for further investigation.

Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase

Zhu, Junsheng,Han, Le,Diao, Yanyan,Ren, Xiaoli,Xu, Minghao,Xu, Liuxin,Li, Shiliang,Li, Qiang,Dong, Dong,Huang, Jin,Liu, Xiaofeng,Zhao, Zhenjiang,Wang, Rui,Zhu, Lili,Xu, Yufang,Qian, Xuhong,Li, Honglin

, p. 1123 - 1139 (2015/03/04)

Human dihydroorotate dehydrogenase (HsDHODH) is a flavin-dependent mitochondrial enzyme that has been certified as a potential therapeutic target for the treatment of rheumatoid arthritis and other autoimmune diseases. On the basis of lead compound 4, which was previously identified as potential HsDHODH inhibitor, a novel series of thiazole derivatives were designed and synthesized. The X-ray complex structures of the promising analogues 12 and 33 confirmed that these inhibitors bind at the putative ubiquinone binding tunnel and guided us to explore more potent inhibitors, such as compounds 44, 46, and 47 which showed double digit nanomolar activities of 26, 18, and 29 nM, respectively. Moreover, 44 presented considerable anti-inflammation effect in vivo and significantly alleviated foot swelling in a dose-dependent manner, which disclosed that thiazole-scaffold analogues can be developed into the drug candidates for the treatment of rheumatoid arthritis by suppressing the bioactivity of HsDHODH.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19241-37-3